Clinical trial

First in Human Study of a Monoclonal Antibody (SOL-116) Targeting BSSL (Bile Salt-Stimulated Lipase), Single and Multiple Dose Parts

NCT05576012

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-10-13

PhasePHASE1

Study timeline

Study start (actual)2022-10-13Date precision: day

Registry last updated2026-01-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

SOL-116BIOLOGICAL

PlaceboBIOLOGICAL

Sponsors & collaborators

Lipum ABlead sponsor

QPS Netherlands B.V.collaborator

Mapped research locations

GroningenNetherlands1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05576012 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.